Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community
September 01 2022 - 12:00PM
Business Wire
Quidel’s QuickVue® assay named “Official
At-Home COVID Test of the Los Angeles Rams”
Quidel Corporation (“Quidel”), a subsidiary of QuidelOrtho
Corporation (NASDAQ: QDEL) and a leading provider of rapid
diagnostic testing solutions, cellular-based virology assays and
molecular diagnostic systems, and the World Champion Los Angeles
Rams today announced a multi-year partnership agreement to promote
health awareness and COVID-19 testing. The agreement makes Quidel
an “Official Partner of the Los Angeles Rams” and designates
Quidel’s QuickVue at-home rapid antigen test as the “Official
At-Home COVID Test of the Los Angeles Rams.” In addition, the
partnership includes a variety of promotions and stadium activation
initiatives as well as a presence at community programs across the
greater Los Angeles area.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220901005588/en/
"As a leading diagnostics company founded and headquartered in
Southern California, Quidel is proud to be an official partner of
the Los Angeles Rams," said Douglas Bryant, Chairman and CEO of
QuidelOrtho. "It is an honor to work close to home and with a
winning organization whose dedication to community service matches
our own. We look forward to teaming up to promote health awareness
and the benefits of COVID-19 testing."
“As we prepare to kick off our season and defend our
championship, we are pleased to welcome Quidel to the Rams family,”
said Rams Chief Commercial Officer Jen Prince. “Quidel’s history in
Southern California and commitment to health and wellness make them
a great fit to help enhance gamedays and our community events
year-round.”
Mr. Bryant noted, “With our 10-minute QuickVue rapid antigen
test taking the field as the ‘Official At-Home COVID Test of the
Los Angeles Rams,’ we will work with the Rams organization to
champion the message of easy and accessible at-home COVID-19
testing at the stadium and further communicate the importance of
testing to all communities through Rams radio, television, and
digital programming.”
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) unites the power of
Quidel Corporation and Ortho Clinical Diagnostics behind a shared
mission of developing and manufacturing innovative technologies
that raise the performance of diagnostic testing and create better
patient outcomes across the entire healthcare continuum.
Ranked among the world’s largest in vitro diagnostics (IVD)
providers with more than 120 years of collective experience, we
combine industry-leading expertise in immunoassay and molecular
testing with a global footprint in clinical labs and transfusion
medicine.
Our company’s comprehensive product portfolio delivers accuracy,
speed, automation, and access, providing critical information when
and where it is needed most. Inspired by a spirit of service, the
QuidelOrtho family is committed to enhancing the well-being of
people worldwide and happy in the knowledge we are making a
difference. For more information, please visit
www.quidelortho.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220901005588/en/
Jeannine Mason, media@Quidel.com Joanna Hunter,
jhunter@rams.nfl.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024